T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM

Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor

FDA Premarket Approval P140015

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the t:slim g4 insulin pump with dexcom g4 platinum cgm (¿t:slim g4 system¿). This device consists of the t:slim g4 insulin pump paired with the dexcom g4 platinum sensor and transmitter. The t:slim g4 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The t:slim g4 insulin pump can be used solely for continuous insulin delivery and as part of the t:slim g4 system to receive and display continuous glucose measurements from the dexcom g4 platinum sensor and transmitter. The t:slim g4 system also includes continuous glucose monitoring (cgm) indicated for detecting trends and tracking patterns in persons with diabetes for use as an adjunctive device to complement, not replace, information obtained from standard home glucose monitoring devices. The t:slim g4 system aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments, which may minimize these excursions. Interpretation of the t:slim g4 system results should be based on the trends and patterns seen with several sequential readings over time. The t:slim g4 system is indicated for use in individuals 12 years of age and greater. The t:slim g4 system is intended for single patient use and requires a prescription.

DeviceT:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM
Classification NamePump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
Generic NamePump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
ApplicantTandem Diabetes Care, Inc.
Date Received2014-07-17
Decision Date2015-09-08
Notice Date2015-10-15
PMAP140015
SupplementS
Product CodeOYC
Docket Number15M-3376
Advisory CommitteeClinical Chemistry
Expedited ReviewNo
Combination Product No
Applicant Address Tandem Diabetes Care, Inc. 11045 Roselle Street san Diego, CA 92121
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140015Original Filing
S029 2019-11-20 30-day Notice
S028 2019-01-16 30-day Notice
S027 2018-09-27 30-day Notice
S026 2018-09-12 30-day Notice
S025 2018-02-01 Real-time Process
S024 2018-01-17 Real-time Process
S023 2018-01-16 30-day Notice
S022 2017-05-16 30-day Notice
S021 2017-04-03 Normal 180 Day Track No User Fee
S020 2017-03-01 Panel Track
S019 2017-01-17 30-day Notice
S018 2016-12-23 30-day Notice
S017 2016-12-21 Real-time Process
S016 2016-12-12 Real-time Process
S015 2016-08-23 30-day Notice
S014 2016-08-10 30-day Notice
S013 2016-08-03 30-day Notice
S012 2016-07-12 Real-time Process
S011 2016-07-11 Real-time Process
S010 2016-06-23 30-day Notice
S009 2016-06-09 30-day Notice
S008 2015-12-30 30-day Notice
S007 2015-12-30 30-day Notice
S006 2015-12-29 Real-time Process
S005 2015-09-18 30-day Notice
S004 2015-09-11 30-day Notice
S003 2015-09-11 30-day Notice
S002 2015-09-11 30-day Notice
S001 2015-09-11 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00853052007967 P140015 000
00852162004408 P140015 000
00852162004415 P140015 000
00852162004422 P140015 000
00852162004439 P140015 000
00852162004613 P140015 000
00852162004750 P140015 000
00853052007226 P140015 000
00853052007233 P140015 000
00853052007257 P140015 000
00853052007271 P140015 000
00853052007295 P140015 000
00853052007318 P140015 000
00853052007981 P140015 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.